Status:
UNKNOWN
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Lead Sponsor:
Inonu University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
15-35 years
Phase:
NA
Brief Summary
The aim of this study is to determine the effect of the treatment of polycystic ovary syndrome with two different oral contraceptives that contain cyproterone acetate and drospirenone
Detailed Description
Polycystic ovary syndrome (PCOS), is the most common endocrinological disorder that affects the reproductive aged women. In addition to causing problems such as menstrual irregularity, hirsutism, acne...
Eligibility Criteria
Inclusion
- Patients who are diagnosed with polycystic ovary syndrome according to Rotterdam criteria and who do not have any additional chronic systemic disease
Exclusion
- The presence of any diseases that cause hormonal disorders and any chronic systemic diseases, the patients who are already under any treatment for polycystic ovary syndrome
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04831151
Start Date
March 1 2021
End Date
June 1 2023
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu University
Malatya, Turkey (Türkiye), 44280